There is considerable scientific evidence supporting the use of antiretroviral therapy (ART)
in prevention of human immunodeficiency virus (HIV) and tuberculosis (TB) infections. The …

In the past several years, the debate of “treatment vs prevention” has shifted with the
introduction of the concept of “treatment as prevention,”(TasP), stemming from a series of …

The evidence in support of use of antiretroviral therapy (ART) for prevention of human
immunodeficiency virus (HIV) transmission is encouraging and has stimulated optimism for …

1. BAckground In 2010, an estimated 34 million people were living with the human
immunodeficiency virus (HIV), around 70% of them in sub-Saharan Africa. By the end of …

Antiretroviral therapy (ART), for those who have access, has revolutionised the morbidity
and mortality consequences of HIV infection. By the end of 2010, 6.6 million people living …

HAART has considerable treatment and prevention benefits and it needs to be considered
as a key element of combination prevention. To explore HAART as an effective prevention …

Antiviral agents can be used to prevent HIV transmission before exposure as preexposure
prophylaxis (PrEP), after exposure as postexposure prophylaxis, and as treatment of …

Research conducted during the first 20 years of the AIDS epidemic provided a solid
foundation of data supporting methadone treatment as HIV prevention. Drug users in …

This review considers the use of antiretroviral drugs specifically to prevent HIV transmission.
Antiretroviral therapy (ART) can be implemented for the protection of uninfected individuals …

Until now, decisions about how to allocate ART have largely been based on maximising the
therapeutic benefit of ART for patients. Since the results of the HPTN 052 study showed …